The management of juxtahepatic venous injuries without an atriocaval shunt: preliminary clinical observations.
Juxtahepatic venous injuries are usually fatal. The optimal method of dealing with these injuries remains controversial, but most experience has been with the insertion of an atriocaval shunt. However, the mortality rate with atriocaval shunting remains prohibitively high (60% to 100%). The experience at the Bellevue Hospital Trauma and Shock Unit during a 9-year period revealed a 50% mortality rate in four consecutive patients who underwent atriocaval shunting. As such, a different approach was used in the following five patients, all of whom survived. One additional patient died in the operating room before any definitive repair could be undertaken. Four steps are considered essential to the successful management of these patients: (1) compression of the injury site until adequate resuscitation has been achieved; (2) early recognition that a juxtahepatic venous injury exists, as indicated by failure of the Pringle maneuver to adequately arrest hemorrhage; (3) prolonged portal triad occlusion with hepatocyte protection by means of large doses of steroids and topical hypothermia (portal triad occlusion time in the nonshunted group ranged from 20 to 64 minutes with a mean occlusion time of 46 minutes; although a transient rise in liver function test results seemed to correlate with the length of ischemia time, neither hepatic dysfunction nor hepatic necrosis occurred; and (4) extensive finger fracture of the liver to the site of vascular injury for primary repair or ligation; the extent of the finger fracture varied from 15 to 30 cm in length and from 5 to 15 cm in depth. The successful results achieved in five consecutive patients who sustained juxtahepatic venous injuries treated without a shunt serve as a basis for recommending this operative approach.
D001803:Blood Transfusion; D003250:Constriction; D006470:Hemorrhage / Q000628:therapy*; D006801:Humans; D007036:Hypothermia, Induced; D008026:Ligation; D008099:Liver / Q000293:injuries*; D008107:Liver Diseases / Q000628:therapy; D008111:Liver Function Tests; D008722:Methods; D008776:Methylprednisolone Hemisuccinate / Q000627:therapeutic use; D011169:Portal Vein / Q000293:injuries* / Q000601:surgery; D013997:Time Factors; D014682:Vena Cava, Inferior / Q000293:injuries* / Q000601:surgery
D008776:Methylprednisolone Hemisuccinate